期刊文献+

前降钙素原在门诊发热患者中诊断细菌感染的价值

Utility of procalcitonin as an diagnostic marker of bacteremia in outpatients with fever
下载PDF
导出
摘要 目的探讨在门诊发热患者中前降钙原诊断细菌感染的价值。方法病例来源于2013年3月—2014年3月我科收治的发热患者,检测血降钙素原,结合细菌培养结果、最终诊断及抗生素治疗结果。评价前降钙素原鉴别细菌感染的诊断价值。结果共纳入216例患者,其中细菌培养阳性患者46例,非细菌感染组170例,分为局部感染组(n=29)、其他疾病组(n=118)和原因不明组(n=23)。降钙素原在细菌感染组明显增高(11.9±23.1vs1.2±10.3 ng/ml,P<0.05)。以0.4 ng/ml为分界点,敏感度和特异度分别是78.26%和80.59%。阴性预测值93.20%。结论针对发热患者,检测血清降钙素原水平可预测细菌感染,而且,低水平的降钙素原可排除细菌感染。因此,降钙素原的检测可指导内科医师抗菌素的合理应用。 Objective: To assess the ability of procalcitonin levels to differentiate bacterial from nonbacterial outpatients with fever. Methods: Serum samples and blood culture were obtained from 216 outpatients with fever between March 2013 and March 2014. We reviewed the final diagnosis and patient histories,including clinical presentation and antibiotic treatment. Results: A total of 216 outpatients with fevers were enrolled in this study: 46 patients with bacteremia( bacterial infection group); 170 withoutbacterial infection( non-bacterial infection group); PCT levels were significantly higher in patients with bacterial infection than in those with non-bacterial infection( 11. 9 ± 23. 1 vs 1. 2 ± 10. 3 ng / m L,P〈0. 001). The sensitivity and specificity were 78. 26% and 80. 59%,the negative predictive value were93. 20%,at a cutoff value of 0. 4 ng / m L. Conclusion In: Febrile outpatients,elevated PCT may help predict bacteremia; furthermore,low PCT levels were helpful for ruling out bacteremia as a diagnosis. Therefore,PCT assessment could help physicians limit the number of prescriptions for antibiotics.
作者 李丽 LI Li(XinJiang Medical University, Wulumuqi 830054, Chin)
机构地区 新疆医科大学
出处 《泰山医学院学报》 CAS 2016年第12期1355-1357,共3页 Journal of Taishan Medical College
关键词 降钙素原 发热 细菌感染 门诊患者 procalcitonin fever bacterial infection outpatient
  • 相关文献

参考文献3

二级参考文献19

  • 1时兢,缪昉,荣菊芬,沈波,穆会君.血清降钙素原检测对院内深部真菌感染诊断价值的探讨[J].内科急危重症杂志,2004,10(4):203-204. 被引量:23
  • 2侵袭性肺部真菌感染的诊断标准与治疗原则(草案)[J].中华内科杂志,2006,45(8):697-700. 被引量:863
  • 3成人严重感染与感染性休克血流动力学监测与支持指南[J].中华内科杂志,2007,46(4):344-349. 被引量:91
  • 4Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med, 2001, 29(7):1303-1310.
  • 5Evans ME, Kortas KJ. Vancomycin use in a university medical center: comparison with hospital infection control practices advisory committee guideline. Infect Control Hosp Epidemiol, 1996, 17(6):356-359.
  • 6Snider RH, Nylen ES, Becker KL. Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization. J Investig Med, 1997, 45(9):552-560.
  • 7American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and multiple organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med, 1992, 20(6):864-874.
  • 8Vincent JL, Moreno R, Takala J, et al. The SOFA score to describe organ dysfunction/failure. Intensive Care Med,1996, 22(7):707-710.
  • 9Oberhoffer M, Vogelsang H, Russwurm S, et al. Outcome prediction by traditional and new markers of inflammation in patients with sepsis. Clin Chem Lab Med, 1999, 37(3):363-368.
  • 10Hausfater P, Garric S, Ayed B, et al. Usefulness of procalcitonin as a marker of systemic infection in emergency department patients: a prospective study. Clin Infect Dis,2002, 34(7):895-901.

共引文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部